Part of the PRO EXO Professional Series — clinical-grade exosome vials for hair transplant surgeons, dermatologists, and aesthetic clinics.
Hair loss research has historically focused on the follicle itself — its cycle, its androgen sensitivity, its vascular supply. The scalp microbiome has received less clinical attention, despite growing evidence that microbial dysbiosis is not merely a cosmetic concern but an active contributor to follicle disruption and inflammation-driven hair loss.
For clinics managing patients with hair loss, scalp sensitivity, or post-procedural recovery, understanding the microbiome's role changes both the diagnostic picture and the treatment approach.
What the scalp microbiome does
The scalp hosts a complex ecosystem of bacteria, fungi, and other microorganisms. In a balanced state, these organisms play a protective role: they compete against pathogenic species, contribute to barrier function, and interact with the immune system in ways that moderate local inflammation.
Dysbiosis — an imbalance in this microbial population — disrupts this protective function. The consequences relevant to hair and scalp health include:
Chronic low-grade inflammation
Dysbiotic microbial populations trigger sustained inflammatory signalling that can push follicles prematurely into the catagen and telogen phases.
Barrier degradation
Disrupted barrier function allows irritants and allergens to penetrate the perifollicular environment, compounding inflammatory load.
Sebum dysregulation
Malassezia species feed on scalp sebum and produce irritant byproducts when overgrown, contributing to seborrheic dermatitis and scalp sensitivity.
Post-procedural vulnerability
Hair transplant and other scalp procedures disrupt the microbiome acutely, creating a window of elevated colonisation risk during recovery.
Clinical presentations that signal microbiome involvement
Microbiome dysbiosis is not always the primary diagnosis, but it is commonly a contributing factor that goes unaddressed. Presentations where microbiome evaluation should be part of the clinical picture:
- Diffuse hair thinning with concurrent scalp sensitivity or itch
- Hair loss that worsens seasonally or with dietary changes
- Persistent dandruff or flaking unresponsive to standard antifungal treatment
- Scalp oiliness that does not respond to sebum-regulating topicals
- Post-transplant scalp that remains irritated beyond the expected acute phase
- AGA patients with poor response to standard protocols
Why antifungal monotherapy is insufficient
The standard clinical response to scalp dysbiosis is antifungal treatment — typically targeting Malassezia overgrowth. This addresses one component of the dysbiotic picture, but it does not restore the broader ecosystem balance that the scalp requires.
A scalp treated with antifungals alone may see Malassezia suppressed while other dysbiotic patterns remain unaddressed. Without restoration of the competitive microbial balance and barrier integrity, recolonisation and symptom recurrence are common.
Effective microbiome management in a clinical context requires an intervention that works across the full dysbiotic picture: suppressing pathogenic organisms, supporting competitive colonisation by commensal species, and reinforcing the barrier function that prevents recolonisation.
The AZOLEI line: microbiome-targeted exosome intervention
The AZOLEI line within the Ossome PRO EXO Series is formulated specifically for scalp microbiome stabilisation. It addresses opportunistic colonisation, reduces the inflammatory signalling associated with dysbiosis, and creates a more stable microenvironment for follicle function.
AZOLEI is most effective as the primary intervention in microbiome-dominant presentations, and as a Phase 2 component in post-transplant recovery protocols where microbial challenge emerges as the dominant concern after the acute inflammatory phase has resolved.
AZOLEI is typically indicated when
- Scalp sensitivity or itch is a significant component of the presentation
- Seborrheic or dandruff history is present alongside hair loss
- Post-transplant scalp enters weeks 2–4 with persistent irritation or flaking
- AGA patients show limited response to cycle-targeted intervention alone
Related reading
Post Hair Transplant Exosome Recovery Protocol →How microbiome stabilisation fits into the full modular protocol for post-FUE and post-FUT recovery.
What are Professional Exosome Scalp Vials? A Clinic Guide →What professional-grade exosome vials are and what separates clinical products from consumer-grade alternatives.
Addressing microbiome imbalance in your clinic?
The Ossome PRO EXO Series including the AZOLEI line is available exclusively to hair transplant surgeons, dermatologists, and aesthetic clinics across Malaysia, Singapore, and Indonesia. Enquire via WhatsApp for protocol guidance and clinical pricing.
Enquire on WhatsApp → View PRO EXO Series